BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 2401043)

  • 1. Differential mechanism for the inhibition of epidermal growth factor binding to its receptor on mouse keratinocytes by anthrones and phorbol esters.
    Imamoto A; Beltrán LM; DiGiovanni J
    Carcinogenesis; 1990 Sep; 11(9):1543-9. PubMed ID: 2401043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for autocrine/paracrine growth stimulation by transforming growth factor-alpha during the process of skin tumor promotion.
    Imamoto A; Beltrán LM; DiGiovanni J
    Mol Carcinog; 1991; 4(1):52-60. PubMed ID: 2009135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of epidermal growth factor binding to cultured mouse epidermal cells by tumor promoters.
    Murray AW; Froscio M
    Carcinogenesis; 1980 Aug; 1(8):681-4. PubMed ID: 11272121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of epidermal akt by diverse mouse skin tumor promoters.
    Lu J; Rho O; Wilker E; Beltran L; Digiovanni J
    Mol Cancer Res; 2007 Dec; 5(12):1342-52. PubMed ID: 18171992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic alterations produced by chrysarobin (1,8-dihydroxy-3-methyl-9-anthrone) in SENCAR mouse skin: relationship to skin tumor promoting activity.
    Kruszewski FH; Naito M; Naito Y; DiGiovanni J
    J Invest Dermatol; 1989 Jan; 92(1):64-71. PubMed ID: 2462598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the mechanism by which a tumor promoter inhibits binding of epidermal growth factor to cellular receptors.
    Lee LS; Weinstein IB
    Carcinogenesis; 1980 Aug; 1(8):669-79. PubMed ID: 11272120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor promoter-induced inhibition of epidermal growth factor binding to cultured mouse primary epidermal cells.
    Lockyer JM; Bowden GT; Matrisian LM; Magun BE
    Cancer Res; 1981 Jun; 41(6):2308-14. PubMed ID: 6972249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of mouse skin tumor promotion by chrysarobin.
    DiGiovanni J; Decina PC; Prichett WP; Cantor J; Aalfs KK; Coombs MM
    Cancer Res; 1985 Jun; 45(6):2584-9. PubMed ID: 3986797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotropin releasing hormone action in pituitary cells. Protein kinase C-mediated effects on the epidermal growth factor receptor.
    Kaji H; Casnellie JE; Hinkle PM
    J Biol Chem; 1988 Sep; 263(27):13588-93. PubMed ID: 2458349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis.
    Chan KS; Carbajal S; Kiguchi K; Clifford J; Sano S; DiGiovanni J
    Cancer Res; 2004 Apr; 64(7):2382-9. PubMed ID: 15059889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmodulation of epidermal growth factor binding by platelet-derived growth factor and 12-O-tetradecanoylphorbol-13-acetate is not sodium-dependent in Balb/c/3T3 cells.
    Olson JE; Pledger WJ
    J Biol Chem; 1990 Feb; 265(4):1847-51. PubMed ID: 2298725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H-7, a protein kinase C inhibitor, inhibits phorbol ester-caused ornithine decarboxylase induction but fails to inhibit phorbol ester-caused suppression of epidermal growth factor binding in primary cultured mouse epidermal cells.
    Nakadate T; Yamamoto S; Aizu E; Nishikawa K; Kato R
    Mol Pharmacol; 1989 Dec; 36(6):917-24. PubMed ID: 2601687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in epidermal polyamine levels and DNA synthesis following topical treatment with chrysarobin in SENCAR mice.
    Kruszewski FH; DiGiovanni J
    Cancer Res; 1988 Nov; 48(22):6390-5. PubMed ID: 3180057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
    Xian W; Rosenberg MP; DiGiovanni J
    Oncogene; 1997 Mar; 14(12):1435-44. PubMed ID: 9136987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the epidermal growth factor receptor by skin tumor promoters and in skin tumors from SENCAR mice.
    Xian W; Kiguchi K; Imamoto A; Rupp T; Zilberstein A; DiGiovanni J
    Cell Growth Differ; 1995 Nov; 6(11):1447-55. PubMed ID: 8562483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of chrysarobin skin tumor promotion.
    DiGiovanni J; Kruszewski FH; Chenicek KJ
    Carcinogenesis; 1988 Aug; 9(8):1445-50. PubMed ID: 3135955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of chrysarobin skin tumor promotion in SENCAR mice by antioxidants.
    Battalora MS; Kruszewski FH; DiGiovanni J
    Carcinogenesis; 1993 Dec; 14(12):2507-12. PubMed ID: 8269619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice.
    Kruszewski FH; Conti CJ; DiGiovanni J
    Cancer Res; 1987 Jul; 47(14):3783-90. PubMed ID: 3109733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phorbol diester and epidermal growth factor receptors in 12-O-tetradecanoylphorbol-13-acetate-resistant and -sensitive mouse epidermal cells.
    Colburn NH; Gindhart TD; Hegamyer GA; Blumberg PM; Delclos KB; Magun BE; Lockyer J
    Cancer Res; 1982 Aug; 42(8):3093-7. PubMed ID: 6284358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor promoting activity of 1,8-dihydroxy-3-methyl-9-anthrone (chrysarobin) in female SENCAR mice.
    DiGiovanni J; Boutwell RK
    Carcinogenesis; 1983; 4(3):281-4. PubMed ID: 6831635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.